Rioja, P, Passarella, C, Angel, M, Valderrama, W, Ainaud, FB, Anguera, G, Gómez, V, Ruiz-Granados, A, Plata, D, Zapata, MI, Orta-Ruiz, A, Quiroga, MNG, Bourlon, MT, Grande, E, Kopp, RM, Molina-Cerrillo, J, Maroto, P, Sade, JP, Castellano, D. Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(7)DOI:10.1016/j.urolonc.2026.04.008. PMID:42139851. IF:2.300(Q2/5D).

Burotto, M, Zvirbule, Z, Alvarez, R, Chewaskulyong, B, Felip, E, Majem, M, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Barata, T, Bustillos, A, Herraez-Baranda, LA, Tosti, N, Young, F, Zanghi, J, Cappuzzo, F. Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies. LUNG CANCER. 2026; 217DOI:10.1016/j.lungcan.2026.109452. PMID:42214243. IF:4.400(Q1/2D).

Olivares-Ripoll, V, Lominchar, PL, Muñoz, P, Ballester, C, Diaz, D, Marrero, P, Cambeiro, L, Lopez, I, Vásquez, H, Casares, CM, Lopez, JAG, Asencio, JM. Are we managing desmoid tumors correctly in Spain? Results of the first national survey. CIRUGIA ESPANOLA. 2026; 104(7)DOI:10.1016/j.ciresp.2026.800333. PMID:. IF:1.300(Q3/7D).

Thwaites, DI, Jornet, N, Georg, D, Muren, L, Thorwarth, D, van Elmpt, W, Aznar, M, Knausl, B, Vedelago, J. A commemoration and appreciation of Professor Ben Mijnheer. RADIOTHERAPY AND ONCOLOGY. 2026; 220DOI:10.1016/j.radonc.2026.111586. PMID:42127568. IF:5.300(Q1/2D).

Martorell, A, Roldán, FA, García-Martínez, FJ, Leyva, AM, Ramírez, JCP, Vilarrasa, E. Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease Staging. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104639. PMID:41865977. IF:(Q/D).

Serra-Baldrich, E, Flórez, A, Manresa, MJ, de Frutos, FJO, Pereyra-Rodriguez, JJ, Pérez, B, Figueras, I. The State of the Art in Chronic Prurigo Nodularis. Dermatology and Therapy. 2026; 16(7)DOI:10.1007/s13555-026-01804-z. PMID:42247108. IF:4.200(Q1/1D).

Rubio-Briones, J, Ramos, FG, Sánchez, AM, Abadía, IB, Rodríguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Martín, MA, Cardo, AL, Rodríguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Ortiz, RE, de Torres, IG, Zalabardo, DS, Guijarro, A, Mengual, L, Borque-Fernando, A, Escaño, LME, Redorta, JP, Witjes, F, Piñeiro, LM. Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study. BJU INTERNATIONAL. 2026; 138(1)DOI:10.1111/bju.70230. PMID:41941336. IF:4.400(Q1/2D).

Lafont, PM, Pelaez, IM, Cuixart, CB. Long-term outcomes of COVID-19 in primary care: 5-Year follow-up of hospitalized and non-hospitalized patients in a population-based cohort study. Medicina De Familia-Semergen. 2026; 52(5)DOI:10.1016/j.semerg.2026.102781. PMID:42235195. IF:(Q/D).